This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on July 17, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Reconstructed Human Small Intestine and Human Skin Models Microtissue Samples and Culture Media

Closed

75F40126Q132991Federal

Submission Closed07/17/2026, 06:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414

New

DIBBS

Reverse Blood Grouping Test Kit Supply (NSN 6550012045367)The contract calls for the supply and delivery of Reverse Blood Grouping Test Kits identified by NSN 6550012045367, with strict adherence to hazardous material handling, packaging, labeling, and technical data submission requirements. Each unit must be clearly marked with expiration dates and contract-specific lot numbers to ensure traceability and compliance throughout the distribution and use lifecycle. The kits are to be delivered to a designated performance location in Williamsburg, Virginia, with a zip code of 23185-5830, and all aspects of the shipment must align with federal hazardous materials regulations. The solicitation, issued under the NAICS code 325414 for Pharmaceutical and Biological Product Manufacturing, is structured as a subcontract and was posted on July 19, 2026, with responses due by July 27, 2026. The contracting entity is part of the Department of Defense’s Medical Supply Chain, specifically under the MD SURG FSF office, indicating the kits are intended for military medical use. All vendors must ensure full compliance with documentation, labeling, and safety standards to meet the operational readiness needs of the defense medical system.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Sterile Medical Pen Manufacturing & PackagingThe contract involves the manufacture and packaging of sterile, disposable skin-marking pens featuring an integrated ruler and gentian violet ink, designed for medical use and required to meet stringent FDA and Department of Defense standards. Each pen must be individually sealed to ensure sterility and compliance with regulatory requirements for safe deployment in clinical and field environments. The product is intended for use in surgical and medical settings where precise skin marking is critical, and the integrated ruler enhances accuracy during procedural preparation. Performance is to be carried out at GROTON, Connecticut, with a response deadline of July 27, 2026, and the contract type is classified as a subcontract under NAICS code 325414, which pertains to medicinal and botanical manufacturing. The overseeing agency is the Department of Defense through the Medical Supply Chain MD Surg FSF, indicating this is part of a broader DoD medical procurement initiative. While no specific set-aside details are provided, the requirement emphasizes adherence to federal quality and safety benchmarks, and bidders must be prepared to demonstrate capability in sterile manufacturing, packaging integrity, and full compliance with military medical supply protocols.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Diagnostic Test Kit Supply (API 20 E)The contract is for the supply of ready-to-use bacterial identification test kits known as API 20 E, specifically designed for the identification of Enterobacteriaceae and other gram-negative rods. These kits are critical diagnostic tools used in medical and clinical settings, requiring strict adherence to shelf-life limitations and continuous refrigeration to maintain efficacy and accuracy. The kits must be delivered in fully functional condition, meeting all stability and storage specifications throughout transport and upon arrival. Performance is localized to Williamsburg, Virginia, with the delivery and handling process ensuring compliance with stringent temperature controls to prevent degradation. This is a subcontract under the Department of Defense’s Medical Supply Chain, managed by the MEDICAL SUPPLY CHAIN MD SURG FSF, with a North American Industry Classification System code of 325414 indicating pharmaceutical and medicinal product manufacturing. The solicitation was posted on July 19, 2026, with a firm deadline for responses on July 27, 2026. All vendors must be prepared to meet the specific operational and logistical demands tied to the sensitive nature of the product, including documentation of cold chain integrity, compliance with federal medical supply standards, and timely delivery to avoid disruption of diagnostic services. No set-aside type is specified, meaning the contract is open to eligible subcontractors regardless of size or certification status.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Bacteriological Specimen Collection and Transportation SystemsThe contract solicits the supply and delivery of bacteriological specimen collection and transportation systems compliant with FDA regulations, specifically designed for use by U.S. Navy vessels operating at FPO addresses. These kits must include appropriate transport media and be packaged and labeled according to stringent military standards to ensure safe, secure, and traceable handling during transit across international and maritime environments. The requirement is issued under the NAICS code 325414 for pharmaceutical and medicine manufacturing and falls under a subcontract structure managed by the Department of Defense through the Medical Supply Chain MD Surg FSF division. All deliveries must be completed to the designated FPO address with zip code 09567, and proposals must be submitted by the deadline of July 27, 2026, with the opportunity posted on July 19, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, BACTERIA DThe contract specifies the procurement of 25 units of the API 20 E bacterial test kit designed for identification of Enterobacteriaceae and other gram-negative rods, with a unit of issue of one package containing 25 kits. The product must be delivered within five days of contract award and must not exceed three months from the date of manufacture to the date of delivery to the government. It requires refrigerated storage between 2 and 8 degrees Celsius and has a non-extendable shelf life of 18 months as a TYPE I (CODE K) item. The item is regulated by the FDA, and buyers must submit a referral through EBS for confirmation, including manufacturer, part number, and supplier details. Packaging must comply with Commercial standards and Medical Marking Standard No. 1, superseding MIL-STD-129, with all containers sealed and robust enough to prevent damage during transit. Hazardous material packaging requirements are applicable if determined by FED-STD-313; otherwise, ASTM D3951 applies unless superseded by DLA technical directives. All packaging and labeling must adhere to DLA’s RP001 packaging requirements and palletization standards. Delivery is FOB destination to the Naval Medical Readiness Logistics Command in Williamsburg, Virginia, with freight shipping required—parcel post is prohibited. The NSN is 6550-01-507-3726, and the manufacturer is BIOMERIEUX INC with part number 20100. The contract solicitation number is SPE2DS-26-T-248X, with a response deadline of July 27, 2026, and an original required delivery date of July 21, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

(Presolicitation Notice) Intent to Sole Source - BioRad AntibodiesThe U.S. Centers for Disease Control and Prevention, through its Office of Acquisition Services under the Department of Health and Human Services, intends to award a sole source contract to Bio-Rad Laboratories for the procurement of Bio-Rad Antibodies. This action is being conducted under the simplified procedures outlined in FAR 12.201-1 and FAR 12.102, which permit non-competitive awards for commercial items when competition is not feasible. A formal solicitation does not exist, and no proposals or quotations will be accepted in response to this notice. Interested parties may submit an Expression of Interest containing detailed technical and pricing information to demonstrate the availability of a comparable source, but submission does not guarantee a competitive opportunity. All submissions must be emailed to AHR0@cdc.gov no later than 1:00 AM ET on August 1, 2026. The government retains full discretion to determine whether to proceed with a sole source award or open the requirement to competition based on the information received. The anticipated place of performance is Atlanta, Georgia, and the North American Industry Classification System code is 325414. The primary point of contact for this action is Emilio Cibula.

CDC Office Of Acquisition Services

POSTED

DEADLINE

Synthetic Nucleic Acid Control Panel ManufacturingThe contract entails the manufacture of synthetic nucleic acid control panel vials specifically designed for in vitro diagnostic use within the FilmArray RP2.1 Assay system. These vials must contain formulated synthetic nucleic acids suspended in a non-infectious buffer that includes stabilizers and preservatives to ensure consistent performance, shelf life, and safety during storage and handling. The production must strictly adhere to quality standards required for diagnostic applications, ensuring accuracy, reproducibility, and compliance with regulatory expectations for in vitro diagnostic reagents. This is a subcontract solicitation issued under the NAICS code 325414 for pharmaceutical preparation, with a response deadline of July 22, 2026, and a posted date of July 16, 2026. The place of performance is designated as FPO with ZIP code 09566-4008, indicating delivery to a military postal location, and the contracting agency is the Department of Defense through its Medical Supply Chain MD Surg FSF. The requirement is part of a broader effort to secure reliable, high-quality diagnostic controls for use in military and federal healthcare diagnostic platforms, with no set-aside provisions specified, allowing full and open competition among qualified subcontractors.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Diagnostic Test Kit SupplyThe contract seeks the supply of commercial off-the-shelf Abbott BinaxNOW COVID-19 Antigen Self Test kits, all of which must have active FDA authorization, a minimum shelf life of 12 months from the date of delivery, and be manufactured as recently as possible to ensure optimal efficacy and reliability. The kits are intended for use in support of medical readiness and health surveillance operations, with all deliveries required to meet strict quality and expiration standards. The sourcing is structured as a subcontract under the Department of Defense’s Medical Supply Chain, specifically managed by the MD SURG FSF office, and performance is to be executed at FPO, 96677. The opportunity was posted on July 16, 2026, with a response deadline of July 22, 2026, and falls under the NAICS code 325414 for in vitro diagnostic substance manufacturing. The procurement is not subject to any set-aside provisions, and the requirement is open to qualified suppliers capable of meeting the specified technical and logistical conditions. All bids must demonstrate compliance with the FDA authorization status, shelf-life requirements, and manufacturing recency to be considered. The contract does not include a designated point of contact, and interested parties must proceed through the official DIBBS platform at the provided link to submit proposals.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Manufacturing of Intravenous Injection Starter KitsThe contract calls for the full assembly and packaging of sterile intravenous starter kits that include a tourniquet, alcohol pad, adhesive bandage, gauze pad, medical tape, exam gloves, and an antiseptic wipe, all manufactured and packaged to meet stringent military standards. The kits must be rendered sterile and properly sealed to ensure safe use in field and clinical environments, requiring adherence to quality control protocols and regulatory requirements associated with medical device assembly for defense applications. The work involves not only the sourcing and integration of components but also verification of sterility, integrity of packaging, and compliance with documentation and traceability mandates specific to defense medical supply chains. This subcontract opportunity is issued under the NAICS code 325414 for pharmaceutical and medicine manufacturing and was posted on July 16, 2026, with a response deadline of July 22, 2026. The contracting entity is the Medical Supply Chain MD Surg FSF within the Department of Defense, indicating the end user is a military medical logistics unit. The place of performance and specific office details are not specified, but the work is likely to require facilities certified for sterile medical assembly and qualified to supply the Department of Defense. Interested parties must submit proposals through the DIBBS portal by the stated deadline to be considered.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Kit Assembly and Component SourcingThe contract calls for the procurement or manufacturing of individual medical components and their assembly into complete lumbar puncture kits, ensuring all final products are packaged in sterile, multi-compartment trays that meet established medical standards. The work involves sourcing sterile and non-sterile parts, rigorous quality control during assembly, and maintenance of aseptic conditions throughout packaging to ensure clinical safety and compliance. All kits must be finalized and delivered in compliance with regulatory and performance requirements for medical devices intended for use in clinical settings. This is a subcontract opportunity under the Department of Defense’s Medical Supply Chain agency, with a NAICS code of 325414 for medical and surgical instrument manufacturing. The solicitation was posted on July 16, 2026, and responses are due by July 22, 2026. Performance location is designated as FPO with a ZIP code of 96672-4090, indicating delivery to a military postal address, likely for use by U.S. military medical units. All parties must adhere to stringent documentation, traceability, and sterilization protocols expected by federal healthcare and defense procurement standards.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supplier of Surgical Medical SuppliesThe contract awards the supply of surgical drainage tubes and related medical items under a Multiple Award IDIQ framework, with deliveries governed by NSN-based delivery orders. It is structured as a subcontract under the Defense Logistics Agency of the Department of Defense, and the North American Industry Classification System code 325414 indicates the focus on pharmaceutical and medicine manufacturing. The contract is set to be active starting on July 16, 2026, and the place of performance and specific office details are not provided, suggesting a broad or flexible fulfillment scope. The absence of a solicitation number and set-aside type implies this is a follow-on or indirect award, potentially part of a larger procurement strategy. Performance is tied to the DLA's DIBBS system, with the contract reference accessible through the provided UI link, indicating that all transactions and modifications are tracked within that platform.

Defense Logistics Agency

POSTED

DEADLINE

Medical Condom Supply and PackagingThe contract entails the supply of female internal condoms that meet stringent medical marking, shelf-life, and packaging standards, ensuring full compliance with FDA requirements. All units must be accompanied by complete batch documentation, and the products must adhere to established regulatory and quality control protocols to guarantee safety, efficacy, and traceability throughout the distribution chain. The items are intended for use within the Department of Defense's medical supply framework, with specific emphasis on meeting federal health and procurement guidelines. This is a subcontract under the Defense Logistics Agency, categorized under NAICS code 325414 for pharmaceutical and medicinal product manufacturing. The solicitation was posted on July 16, 2026, and the performance location and point of contact details are not specified, indicating that logistics and delivery arrangements are likely managed through centralized DLA channels. The contract is linked to the DIBBS system under award number SPE2DS26P2483, facilitating transparent tracking and accountability for all delivered products.

Defense Logistics Agency

POSTED

4 days ago

DEADLINE

N/A

AI Contract Overview

The U.S. Food and Drug Administration’s Office of Acquisition and Grant Services is soliciting bids for reconstructed human small intestine and human skin models, along with associated microtissue samples and culture media, under solicitation number 75F40126Q132991. This is a total small business set-aside as defined under FAR 19.5, exclusively available to small businesses certified by the Small Business Administration, with the North American Industry Classification System code 325414 covering pharmaceutical and biological product manufacturing. All proposals must be submitted by 6:00 PM Eastern Time on July 17, 2026, and the contract will be awarded for performance at a location in Jefferson, Arkansas, with deliveries expected to meet strict biological and quality standards for research and regulatory applications. The primary point of contact for this solicitation is Howard Nesmith, reachable via email at howard.nesmith@fda.hhs.gov or by phone at 301-796-2138, and inquiries should be directed to him for clarification. The solicitation combines the synopsis and request for proposals into a single document, and interested parties must access the full details through the official SAM.gov portal. The contract is managed under the Department of Health and Human Services, with the issuing office headquartered in Rockville, Maryland. All submissions must comply with federal acquisition regulations and demonstrate the capability to consistently supply high-fidelity, biologically relevant human tissue models suitable for preclinical testing and scientific validation.